Literature DB >> 6963747

The nosocomial component of medical care. A prospective study on the amount, spectrum and costs of medical disturbances in a department of infectious diseases.

C Jorup-Rönström, S Britton.   

Abstract

During a nine month period all patients admitted to a department of infectious diseases were prospectively studied regarding nosocomial reactions defined as any unwanted or unexpected negative effect of medical treatment or care. Eleven percent of 1271 patients were admitted because of complications to previous medical treatment. Twenty-seven percent of the patients developed adverse reactions during the hospital stay. Only four percent of these resulted in a prolonged hospital stay. Six patients (0.5%) died from complications to medical care. We deduce that medical complications are not a major factor in prolonging hospital stay, but rather that the longer the hospital stay the greater the risk for developing nosocomial symptoms. The estimated cost for the whole of the nosocomial matter was seventeen percent of the budget of the department.

Entities:  

Mesh:

Year:  1982        PMID: 6963747

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  4 in total

1.  Could Swedish 'yellow cards' be substituted by E-coded summaries?

Authors:  C Jorup-Rönström; M Keisu; B E Wiholm
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

2.  The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas.

Authors:  C Jorup-Rönström; S Britton; A Gavlevik; K Gunnarsson; A C Redman
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

3.  Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial.

Authors:  Philippe Bernard; Olivier Chosidow; Loïc Vaillant
Journal:  BMJ       Date:  2002-10-19

4.  Epidemiologic patterns of nosocomial infections in 10 Oklahoma hospitals.

Authors:  S L Silberg; C G Torres; W L Owen; D E Parker; B R Neas
Journal:  J Natl Med Assoc       Date:  1993-11       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.